glimepiride has been researched along with Liver Dysfunction in 1 studies
glimepiride: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
" Pharmacokinetic data on sulfonylureas are generally inconsistent in cirrhotic patients." | 2.39 | Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients. ( Rosenkranz, B, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosenkranz, B | 1 |
1 review available for glimepiride and Liver Dysfunction
Article | Year |
---|---|
Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Di | 1996 |